Asmaa Mostafa Abdelaal Mohamed <br/><br/>
Human Interleukin 12 gene as a biomarker for response to interferon treatment in hepatitis C virus patients /  
 جين الإنترلوكين 12 فى الانسان كدليل حيوى للإستجابة لعلاج الإنترفيرون فى المرضى المصابين بفيروس الإلتهاب الكبدى الوبائى سى 
Asmaa Mostafa Abdelaal Mohamed ; Supervised Samar Samir Youssef , Amr Saad Mohamed 
 - Cairo :   Asmaa Mostafa Abdelaal Mohamed ,   2013 
 - 135 P. :   charts ;   25cm 
<br/><br/>Thesis (M.Sc.) - Cairo University - Faculty of Science - Department of Biochemistry 
<br/><br/> Introduction: Hepatitis C virus (HCV) infection"The silent killer" is a global blood-borne disease that affects almost 3% of the worlds population with the highest prevalence in Egypt (15%). the standard therapy, PEG-IFN and ribavirin , is effective in only 60% of Egyptian patients; moreover it is costly, prolonged and have severe side effects, so prediction of response is essential to reduce burden of unfavorable treatment 
<br/><br/>
<br/><br/><label>Subjects--Index Terms: </label>Hepatitis C virus (HCV)  IL 12 gene  Response to PEG-IFN therapy